Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

December 16, 2025 Drug delivery / Pharma applications

A host-guest mediated immunomodulatory hydrogel with sustained antibacterial activity for healing of infected diabetic wounds

To solve the hinderance of infected diabetic wound regeneration and healing, an antibacterial and immunomodulatory hydrogel based on host-guest mediated

Continue reading

December 15, 2025 CD as API / CD derivatives / Pharma applications

Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis

/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,

Continue reading

December 11, 2025 CD as API / Pharma applications

Biomimetic cyclodextrin enzyme models for modulation of P. aeruginosa quorum sensing and host immune response

Quorum sensing (QS) is the cell-to-cell communication on cell density, which is based on signal molecules,  N-acyl-homoserine lactones (AHLs) for

Continue reading

December 8, 2025 Drug delivery / Pharma applications

Fungal quorum sensing molecules as potential drugs in the treatment of chronic wounds and their delivery

Interestingly fungal quorum sensing signal molecules (QSMs) were found effective against bacterial biofilms hindering the healing of chronic non-healing wounds

Continue reading

December 4, 2025 CD derivatives / Drug delivery / Pharma applications

Novel delivery systems for Resveratrol

A novel polymer, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC) was synthesized to evaluate its potential as an efficient carrier for the encapsulation of

Continue reading

european commission flags on poles
December 2, 2025 CD derivatives / Pharma applications

First EMA regulation on the residues of betadex sulfobutylether sodium in foodstuffs of animal

Regulation (European Commission) No. 470/2009 lays down Community procedures for the establishment of residue limits of pharmaceutical active substances, excipients

Continue reading

December 1, 2025 CD as API / CD derivatives / Drug delivery / Pharma applications

From an Idea to a Journey: My Path Toward Treating Gout and Hyperuricemia With Cyclodextrins

When I look back at the last few years, it’s hard not to feel moved by what this project has

Continue reading

November 28, 2025 Drug delivery / Pharma applications

Beta-cyclodextrin/salicylic acid complex in pads for wart treatment

A novel product labeled as “SottSunFeli Maximum strength wart remover patches” containing beta-cyclodextrin and 30% salicylic acid as active ingredient

Continue reading

November 25, 2025 Drug delivery / Pharma applications

Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment

In a recent study, Professors Bodor and Buchwald review the use of cyclodextrin-enabled formulations to develop oral tablets of cladribine

Continue reading

Posts pagination

«Previous Posts 1 … 4 5 6 7 8 … 125 Next Posts»

Recent Posts

  • HPβCD’s Promise in Treating Ischemic Stroke
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (340)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,157)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • HPβCD's Promise in Treating Ischemic Stroke
  • Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
  • Lanosterol eye drops for cataract treatment
  • Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application
  • Sun-protective clothing using benzophenone/CD complex
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
  • Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...